quinoxalines has been researched along with Congenital Zika Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ali, A; Johnson, C; Jordan, A; Kurt Yilmaz, N; Nalivaika, EA; Rao, DN; Schiffer, CA; Shaqra, AM; Zephyr, J | 1 |
1 other study(ies) available for quinoxalines and Congenital Zika Syndrome
| Article | Year |
|---|---|
Allosteric quinoxaline-based inhibitors of the flavivirus NS2B/NS3 protease.
Topics: Antiviral Agents; Flavivirus; Humans; Peptide Hydrolases; Protease Inhibitors; Quinoxalines; Serine Endopeptidases; Viral Nonstructural Proteins; Zika Virus; Zika Virus Infection | 2023 |